Paper32807487
Routine use of FLAIR-negative MRI in the treatment of unknown onset stroke.
Adil MM and 7 others. J Stroke Cerebrovasc Dis, 2020. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Routine use of FLAIR-negative MRI in the treatment of unknown onset stroke. Papers, record 32807487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32807487
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibrinolytic Agents | Major topic |
| Magnetic Resonance Imaging | Major topic |
| Stroke | Major topic |
| Thrombolytic Therapy | Major topic |
| Tissue Plasminogen Activator | Major topic |
| Aged | |
| Aged, 80 and over | |
| Clinical Decision-Making | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Patient Selection | |
| Predictive Value of Tests | |
| Registries | |
| Retrospective Studies | |
| Time Factors | |
| Time-to-Treatment | |
| Treatment Outcome |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| ZIA NS003151 | Intramural NIH HHS | United States | ZIANS003151 | PubMed |
Source NIH RePORTER
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17258667 | Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. | Lancet | 2007 | https://conductscience.org/library/papers/17258667 | PubMed |
| 2 | 29843148 | Target Door-to-Needle Time for Tissue Plasminogen Activator Treatment with Magnetic Resonance Imaging Screening Can Be Reduced to 45 min. | Cerebrovasc Dis | 2018 | https://conductscience.org/library/papers/29843148 | PubMed |
| 3 | 29766770 | MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29766770 | PubMed |
| 4 | 28174327 | Stroke With Unknown Time of Symptom Onset: Baseline Clinical and Magnetic Resonance Imaging Data of the First Thousand Patients in WAKE-UP (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke: A Randomized, Doubleblind, Placebo-Controlled Trial). | Stroke | 2017 | https://conductscience.org/library/papers/28174327 | PubMed |
| 5 | 29689135 | Intravenous thrombolysis in unwitnessed stroke onset: MR WITNESS trial results. | Ann Neurol | 2018 | https://conductscience.org/library/papers/29689135 | PubMed |
| 6 | 28722240 | An MRI Hyperintense Acute Reperfusion Marker Is Related to Elevated Peripheral Monocyte Count in Acute Ischemic Stroke. | J Neuroimaging | 2018 | https://conductscience.org/library/papers/28722240 | PubMed |
| 7 | 22693129 | A pragmatic approach using magnetic resonance imaging to treat ischemic strokes of unknown onset time in a thrombolytic trial. | Stroke | 2012 | https://conductscience.org/library/papers/22693129 | PubMed |
| 8 | 11935049 | The stroke patient who woke up: clinical and radiological features, including diffusion and perfusion MRI. | Stroke | 2002 | https://conductscience.org/library/papers/11935049 | PubMed |
| 9 | 31662118 | Quantitative Signal Intensity in Fluid-Attenuated Inversion Recovery and Treatment Effect in the WAKE-UP Trial. | Stroke | 2020 | https://conductscience.org/library/papers/31662118 | PubMed |
| 10 | 31662037 | Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. | Stroke | 2019 | https://conductscience.org/library/papers/31662037 | PubMed |
| 11 | 21555734 | Population-based study of wake-up strokes. | Neurology | 2011 | https://conductscience.org/library/papers/21555734 | PubMed |
| 12 | 30571437 | Implications of the WAKE-UP Trial. | Stroke | 2018 | https://conductscience.org/library/papers/30571437 | PubMed |
| 13 | 9788453 | Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. | Lancet | 1998 | https://conductscience.org/library/papers/9788453 | PubMed |
| 14 | 25972494 | Screening with MRI for Accurate and Rapid Stroke Treatment: SMART. | Neurology | 2015 | https://conductscience.org/library/papers/25972494 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40104262 | Mitigating Early Phosphatidylserine Exposure in a Tmem30a-Dependent Way Ameliorates Neuronal Damages After Ischemic Stroke. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40104262 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PLAT | 5327 | PubTator's text mining | https://conductscience.org/library/genes/5327 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32807487
GET https://conductscience.org/api/papers/v1/32807487/authors